Taking rivaroxaban is a risk factor for acute kidney disease and disorders in patients with coronary heart disease or non-valvular atrial fibrillation

Li Wen, Dong Xingtong, Jia Qiang, Fu Wenjing, Lin Na, Liu Hua, Zhang Aihua

PDF(908 KB)
Chinese Journal of Nephrology
Chinese Journal of Nephrology ›› 2020, Vol. 36 ›› Issue (10) : 744-749. DOI: 10.3760/cma.j.cn441217-20191101-00132
Clinical Study

Taking rivaroxaban is a risk factor for acute kidney disease and disorders in patients with coronary heart disease or non-valvular atrial fibrillation

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 36(10): 744-749. DOI: 10.3760/cma.j.cn441217-20191101-00132.

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(908 KB)

Accesses

Citation

Detail
Sections
Recommended

Copyright© by the Editorial Board of Chinese Journal of Nephrology, Chinese Medical Association and the First Affiliated Hospital of Sun Yat-sen University (Guangzhou) Journal Co., Ltd

Address: Floor 2, Longzhu building, No. 5, Zhusigang Second Road, Yuexiu District, Guangzhou (510080) Tel：(020)87331532　Email：cmaszb@mail.sysu.edu.cn

This system is designed and developed by Beijing magtec Technology Development Co., Ltd. with technical support: support@magtech.com.cn

粤ICP备10090623号

/

〈 〉